$CLRB stock has now fallen 18% today, according to our price data from Polygon. There has been approximately $1,911,864 of trading volume.
Here is what we see in our data on $CLRB (you can track the company live on Quiver's $CLRB stock page):$CLRB Insider Trading Activity
$CLRB insiders have traded $CLRB stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLRB stock by insiders over the last 6 months:
- JAMES V CARUSO (Chief Executive Officer) purchased 10,000 shares for an estimated $49,900
- JARROD LONGCOR (Chief Operating Officer) purchased 10,000 shares for an estimated $49,900
- CHAD J KOLEAN (Chief Financial Officer) purchased 5,000 shares for an estimated $24,950
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLRB Hedge Fund Activity
We have seen 2 institutional investors add shares of $CLRB stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAADER BANK AKTIENGESELLSCHAFT removed 172,940 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,229,603
- VANGUARD GROUP INC removed 57,395 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $408,078
- UBS GROUP AG removed 30,678 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $218,120
- GEODE CAPITAL MANAGEMENT, LLC removed 14,780 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $105,085
- SQUAREPOINT OPS LLC removed 12,362 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $87,893
- CITADEL ADVISORS LLC removed 11,442 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $81,352
- BLACKROCK, INC. removed 7,693 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $54,697
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
You can track data on $CLRB on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
